| Literature DB >> 1776746 |
F M Corrigan1, A Van Rhijn, D F Horrobin.
Abstract
Concentrations of essential fatty acids (EFAs) in plasma and red blood cell phospholipids were found to be abnormal in patients with Alzheimer's disease. A double-blind, placebo-controlled trial of treatment with EFAs plus appropriate antioxidants was carried out in 36 patients with Alzheimer's disease. After 20 weeks both the EFA and placebo groups had improved, but the degree of improvement was consistently greater in the EFA group.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1776746 DOI： 10.1111/j.1749-6632.1991.tb00228.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691